86.22.Z - Specialist medical practice activities
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
86.21.Z - General medical practice activities
86.90.E - Other human health activities notelsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 1,1 | 1,5 | 2 | 28 |
Liabilities and provisions | 0,7 | 0,3 | 1,1 | 238,8 |
Equity | 0 | 0,2 | 0,6 | 214,1 |
Total assets | 0,7 | 0,5 | 1,7 | 229,4 |
Depreciation | 0 | 0 | 0 | 0 |
Cash and cash equivalents | 0,7 | 0,4 | 0,3 | -11,3 |
Gross profit / loss | 0 | 0,2 | 0,5 | 182,7 |
EBITDA | 0 | 0,2 | 0,5 | 184,4 |
Operating profit (EBIT) | 0 | 0,2 | 0,5 | 184,4 |
Current assets | 0,7 | 0,5 | 0,6 | 13,7 |
Net profit / loss | 0 | 0,1 | 0,4 | 180,9 |
% | % | % | p.p. | |
Return on equity (ROE) | 89,2 | 76,2 | 68,2 | -8 |
Return on sales (ROS) | 3,9 | 9,7 | 21,2 | 11,5 |
Equity ratio | 6,4 | 38,1 | 36,3 | -1,8 |
EBITDA margin | 4,3 | 10,5 | 23,4 | 12,9 |
Gross profit margin | 4,3 | 10,6 | 23,4 | 12,8 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 236 | 75 | 62 | -13 |
Current ratio | 1,1 | 1,6 | 1,7 | 0,1 |
Net debt to EBITDA | -15,3 | -2,2 | 1 | 3,2 |